Share on StockTwits

Investment analysts at Investec lifted their price objective on shares of Bodycote PLC (LON:BOY) from GBX 760 ($12.91) to GBX 775 ($13.16) in a note issued to investors on Thursday. The firm currently has a “buy” rating on the stock. Investec’s price objective suggests a potential upside of 12.73% from the company’s current price.

Bodycote PLC (LON:BOY) traded down 0.94% on Thursday, hitting GBX 687.50. The stock had a trading volume of 193,564 shares. Bodycote PLC has a 52-week low of GBX 595.00 and a 52-week high of GBX 832.00. The stock’s 50-day moving average is GBX 693.1 and its 200-day moving average is GBX 726.1. The company’s market cap is £1.308 billion.

The company also recently declared a dividend, which is scheduled for Friday, November 7th. Shareholders of record on Wednesday, October 1st will be given a dividend of GBX 4.60 ($0.08) per share. This represents a yield of 0.66%. The ex-dividend date of this dividend is Wednesday, October 1st.

Several other analysts have also recently commented on the stock. Analysts at N+1 Singer reiterated a “buy” rating on shares of Bodycote PLC in a research note on Thursday. They now have a GBX 850 ($14.43) price target on the stock. Separately, analysts at FinnCap reiterated a “hold” rating on shares of Bodycote PLC in a research note on Thursday. They now have a GBX 750 ($12.74) price target on the stock. Finally, analysts at Berenberg Bank upgraded shares of Bodycote PLC to a “buy” rating in a research note on Friday, July 25th. They now have a GBX 776 ($13.18) price target on the stock, up previously from GBX 759 ($12.89). Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and eight have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of GBX 889.17 ($15.10).

Bodycote plc (LON:BOY) is a specialized plasma spray, high velocity oxy fuel (HVOF) and thermally formed ceramic treatments.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.